Cargando…
Systems Pharmacology and Rational Polypharmacy: Nitric Oxide−Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case
Impaired nitric oxide (NO˙)-cyclic guanosine 3', 5'-monophosphate (cGMP) signaling has been observed in many cardiovascular disorders, including heart failure and pulmonary arterial hypertension. There are several enzymatic determinants of cGMP levels in this pathway, including soluble gua...
Autores principales: | Garmaroudi, Farshid S., Handy, Diane E., Liu, Yang-Yu, Loscalzo, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795786/ https://www.ncbi.nlm.nih.gov/pubmed/26985825 http://dx.doi.org/10.1371/journal.pcbi.1004822 |
Ejemplares similares
-
Nitric oxide regulated cyclic di-GMP signaling
por: Boon, Elizabeth M, et al.
Publicado: (2013) -
Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets
por: Kleppe, Rune, et al.
Publicado: (2018) -
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development
por: Murad, Ferid
Publicado: (2012) -
The Nitric Oxide-Cyclic GMP Pathway Regulates FoxO and Alters Dopaminergic Neuron Survival in Drosophila
por: Kanao, Tomoko, et al.
Publicado: (2012) -
Mangiferin Prevents Guinea Pig Tracheal Contraction via Activation of the Nitric Oxide-Cyclic GMP Pathway
por: Vieira, Aline B., et al.
Publicado: (2013)